This inventor holds 3 USPTO granted patents. Top assignee: The United States Government as Represented by the Department of Veterans Affairs. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Katherine Meyer Siegler: Innovator in Urological Health
Introduction
Katherine Meyer Siegler is a notable inventor based in Seminole, FL (US). She has made significant contributions to the field of urological health, particularly through her innovative research and patents. With a total of 3 patents, her work focuses on the diagnosis and treatment of urological inflammatory diseases and prostate cancer.
Latest Patents
One of her latest patents is titled "Macrophage migration inhibitory factor (MIF) as marker for urological inflammatory disease." This invention relates to the detection and quantification of MIF in urine, bladder, and prostate tissues. It aims to assist in the diagnosis and prognosis of urological inflammatory diseases such as chronic pelvic pain syndrome, non-bacterial prostatitis, and interstitial cystitis. The patent also discusses methods to inactivate MIF activity using antibodies or specific inhibitors to treat these conditions.
Another significant patent is "Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer." This invention focuses on the risk assessment and detection of prostate cancer through the identification of specific polymorphisms in the MIF gene's promoter region. The findings indicate that certain genetic variations predispose individuals to prostate cancer, enhancing the potential for early diagnosis and treatment.
Career Highlights
Katherine Meyer Siegler is currently employed by the United States Government as represented by the Department of Veterans Affairs. Her work in this capacity has allowed her to contribute to important advancements in medical research and patient care.
Collaborations
She has collaborated with notable colleagues, including Pedro L Vera and Kenneth Iczkowski, to further her research and innovations in the field.
Conclusion
Katherine Meyer Siegler's contributions to urological health through her patents and research are invaluable. Her work not only enhances the understanding of urological inflammatory diseases and prostate cancer but also paves the way for improved diagnostic and treatment options.